• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Gaxos.ai Inc.

    6/30/25 4:19:10 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology
    Get the next $GXAI alert in real time by email
    DEFA14A 1 ny20050857x2_defa14a.htm DEFA14A
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Schedule 14A
    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934
    (Amendment No. )
     
     
     
     
    Filed by the Registrant
     
     
    ☒
    Filed by a Party other than the Registrant
     
     
     ☐
     
     
     
     
    Check the appropriate box:
     ☐
    Preliminary Proxy Statement
     ☐
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ☐
    Definitive Proxy Statement
     ☒
    Definitive Additional Materials
     ☐
    Soliciting Material under § 240.14a-12
     
    GAXOS.AI INC.
    (Name of Registrant as Specified In Its Charter)
     
     
    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
     
    Payment of Filing Fee (Check all boxes that apply):
    ☒
    No fee required
     ☐
    Fee paid previously with preliminary materials
     ☐
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a- 6(i)(1) and 0-11



















    Get the next $GXAI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GXAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GXAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gaxos Labs Launches Art-Gen, an AI Image and Video Creation Platform Targeting Multi-Billion Dollar Market

    Roseland, NJ, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Art-Gen.AI, an AI image and video creation platform that makes pro-grade content effortless for anyone, anywhere. Art-Gen combines state-of-the-art AI models from industry leaders including Google, Stability AI, and PixVerse with Gaxos' proprietary enhancements to deliver unmatched creative speed, detail, and flexibility. With just a simple text prompt or reference image, users can instantly produce cinematic visuals, hyper-realistic imagery, or animated video content

    8/19/25 8:00:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    Gaxos Labs Launches UnGPT.ai Setting a New Standard in Humanized AI

    Roseland, NJ, May 21, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of UnPGT.ai, a tool that makes text created by generative artificial intelligence sound natural and human. UnGPT introduces a real-time rewriting engine designed to convert machine-generated text into authentic, human-quality content without compromising meaning or context. UnGPT uses a proprietary multi-pass transformation model that outperforms leading AI detection tools and addresses one of the industry's fastest growing concerns: the need for undetectable, high-quality output in se

    5/21/25 8:00:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    Gaxos Labs Approved for Listing on Amazon Web Services (AWS) Marketplace

    Roseland, NJ , May 07, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its product, Gaxos Labs for Game Developers and Publishers, has been officially approved for listing on Amazon Web Services (AWS) Marketplace, one of the cloud industry's largest software distribution platforms.  The approval marks a significant milestone in the Company's go-to-market strategy, enabling seamless deployment of Gaxos Labs by millions of AWS customers across 245 countries and territories. AWS Marketplace listing streamlines procurement for enterprise clients, simplifies software billi

    5/7/25 8:00:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    SEC Filings

    View All

    $GXAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Gaxos.ai Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - GAXOS.AI INC. (0001895618) (Filer)

    8/13/25 4:15:59 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-Q filed by Gaxos.ai Inc.

    10-Q - GAXOS.AI INC. (0001895618) (Filer)

    8/13/25 4:00:23 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEFA14A filed by Gaxos.ai Inc.

    DEFA14A - GAXOS.AI INC. (0001895618) (Filer)

    6/30/25 4:19:10 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Holzer Adam

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:03:36 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Grayson Scott

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:02:46 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Feldman Roman

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:01:32 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Financials

    Live finance-specific insights

    View All

    Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App

    Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio

    3/13/24 8:30:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Leadership Updates

    Live Leadership Updates

    View All

    Gaxos Health Expands Medical Advisory Board

    Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D.  is a Board-Ce

    4/25/24 8:45:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Gaxos.ai Inc.

    SC 13G - GAXOS.AI INC. (0001895618) (Subject)

    11/14/24 3:30:50 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology